Mahana develops innovative digital therapeutic programs aimed at improving the quality of life for individuals with chronic health conditions. Their flagship products, Mahana™ IBS and Mahana Tinnitus, are designed to provide self-guided support through smartphone-enabled platforms. These programs are clinically tested to ensure they deliver effective physical and psychological support, empowering users to manage their conditions on their own terms. By collaborating with expert clinicians, designers, and engineers, Mahana has created personalized solutions that are informed by the experiences of patients themselves.

The company places a strong emphasis on data security and regulatory compliance, ensuring that user information is protected while seeking necessary approvals from agencies like the FDA. Mahana's commitment to rigorous clinical trials underscores their dedication to demonstrating the efficacy of their programs, which are intended to enhance the patient-provider relationship by being accessible through recommendations or prescriptions from healthcare providers. With a focus on cognitive and behavioral therapy, Mahana aims to address the needs of the over one billion people worldwide suffering from chronic health issues.

United States

We're developing digital treatments for people living with chronic health conditions.

Mahana

Company Details